COMPANY
Shanton Pharma
Timeline
- Trial start Phase 1: SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects source ↗
- Trial start Phase 2: Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients source ↗
- Trial start Phase 1: Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients source ↗
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06678581 | SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects | Phase 1 | Completed | May 29, 2023 | Dec 20, 2023 (actual) |
| NCT04040816 | Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients | Phase 2 | Completed | Jan 1, 2019 | Aug 1, 2020 (actual) |
| NCT03857165 | Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients | Phase 1 | Completed | Sep 24, 2018 | Jun 2, 2019 (actual) |